Cargando…

Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement

BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Kashish, O’Leary, Jared M., Barker, Colin M., Levack, Melissa, Rajagopal, Vivek, Makkar, Raj R., Bajwa, Tanvir, Kleiman, Neal, Linke, Axel, Kereiakes, Dean J., Waksman, Ron, Allocco, Dominic J., Rizik, David G., Reardon, Michael J., Lindman, Brian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660783/
https://www.ncbi.nlm.nih.gov/pubmed/32856530
http://dx.doi.org/10.1161/JAHA.120.017075
_version_ 1783609080674254848
author Goel, Kashish
O’Leary, Jared M.
Barker, Colin M.
Levack, Melissa
Rajagopal, Vivek
Makkar, Raj R.
Bajwa, Tanvir
Kleiman, Neal
Linke, Axel
Kereiakes, Dean J.
Waksman, Ron
Allocco, Dominic J.
Rizik, David G.
Reardon, Michael J.
Lindman, Brian R.
author_facet Goel, Kashish
O’Leary, Jared M.
Barker, Colin M.
Levack, Melissa
Rajagopal, Vivek
Makkar, Raj R.
Bajwa, Tanvir
Kleiman, Neal
Linke, Axel
Kereiakes, Dean J.
Waksman, Ron
Allocco, Dominic J.
Rizik, David G.
Reardon, Michael J.
Lindman, Brian R.
author_sort Goel, Kashish
collection PubMed
description BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function post‐TAVR are unknown. METHODS AND RESULTS: The REPRISE III (Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System–Randomized Clinical Evaluation) trial randomized high/extreme risk patients to receive a mechanically‐expanded or self‐expanding transcatheter heart valve. Of 874 patients who underwent TAVR, 576 with complete data at baseline and 1 year were included in this analysis. Slow gait speed in the 5‐m walk test was defined as <0.83 m/s. A clinically meaningful improvement (≥0.1 m/s) in gait speed 1 year after TAVR occurred in 39% of patients, 35% exhibited no change, and 26% declined (≥0.1 m/s). Among groups defined by baseline/1‐year post‐TAVR gait speeds, 1‐ to 2‐year mortality or hospitalization rates were as follows: 6.6% (normal/normal), 8.0% (slow/normal), 20.9% (normal/slow), and 21.5% (slow/slow). After adjustment, slow gait speed at 1 year (regardless of baseline speed) was associated with a 3.5‐fold increase in death/hospitalization between 1 and 2 years compared with those with normal baseline/1‐year gait speed. Patients whose slow gait speed normalized at 1 year had no increased risk. One‐year, but not baseline, gait speed was associated with death or hospitalization between 1 and 2 years (adjusted hazard ratio, 0.83 per 0.1 m/s faster gait; 95% CI, 0.74–0.93, P=0.001). CONCLUSIONS: Marked heterogeneity exists in the trajectory of physical function after TAVR and this, more than baseline function, has clinical consequences. Identifying and optimizing factors associated with physical resilience after TAVR may improve outcomes. REGISTRATION: URL: https://www.clini​caltr​ials.gov; Unique identifier: NCT02202434.
format Online
Article
Text
id pubmed-7660783
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76607832020-11-17 Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement Goel, Kashish O’Leary, Jared M. Barker, Colin M. Levack, Melissa Rajagopal, Vivek Makkar, Raj R. Bajwa, Tanvir Kleiman, Neal Linke, Axel Kereiakes, Dean J. Waksman, Ron Allocco, Dominic J. Rizik, David G. Reardon, Michael J. Lindman, Brian R. J Am Heart Assoc Original Research BACKGROUND: Gait speed is a reliable measure of physical function and frailty in patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Slow gait speed pre‐TAVR predicts worse clinical outcomes post‐TAVR. The consequences of improved versus worsened physical function post‐TAVR are unknown. METHODS AND RESULTS: The REPRISE III (Repositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus Valve System–Randomized Clinical Evaluation) trial randomized high/extreme risk patients to receive a mechanically‐expanded or self‐expanding transcatheter heart valve. Of 874 patients who underwent TAVR, 576 with complete data at baseline and 1 year were included in this analysis. Slow gait speed in the 5‐m walk test was defined as <0.83 m/s. A clinically meaningful improvement (≥0.1 m/s) in gait speed 1 year after TAVR occurred in 39% of patients, 35% exhibited no change, and 26% declined (≥0.1 m/s). Among groups defined by baseline/1‐year post‐TAVR gait speeds, 1‐ to 2‐year mortality or hospitalization rates were as follows: 6.6% (normal/normal), 8.0% (slow/normal), 20.9% (normal/slow), and 21.5% (slow/slow). After adjustment, slow gait speed at 1 year (regardless of baseline speed) was associated with a 3.5‐fold increase in death/hospitalization between 1 and 2 years compared with those with normal baseline/1‐year gait speed. Patients whose slow gait speed normalized at 1 year had no increased risk. One‐year, but not baseline, gait speed was associated with death or hospitalization between 1 and 2 years (adjusted hazard ratio, 0.83 per 0.1 m/s faster gait; 95% CI, 0.74–0.93, P=0.001). CONCLUSIONS: Marked heterogeneity exists in the trajectory of physical function after TAVR and this, more than baseline function, has clinical consequences. Identifying and optimizing factors associated with physical resilience after TAVR may improve outcomes. REGISTRATION: URL: https://www.clini​caltr​ials.gov; Unique identifier: NCT02202434. John Wiley and Sons Inc. 2020-08-28 /pmc/articles/PMC7660783/ /pubmed/32856530 http://dx.doi.org/10.1161/JAHA.120.017075 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Goel, Kashish
O’Leary, Jared M.
Barker, Colin M.
Levack, Melissa
Rajagopal, Vivek
Makkar, Raj R.
Bajwa, Tanvir
Kleiman, Neal
Linke, Axel
Kereiakes, Dean J.
Waksman, Ron
Allocco, Dominic J.
Rizik, David G.
Reardon, Michael J.
Lindman, Brian R.
Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title_full Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title_fullStr Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title_full_unstemmed Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title_short Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement
title_sort clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve replacement
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660783/
https://www.ncbi.nlm.nih.gov/pubmed/32856530
http://dx.doi.org/10.1161/JAHA.120.017075
work_keys_str_mv AT goelkashish clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT olearyjaredm clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT barkercolinm clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT levackmelissa clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT rajagopalvivek clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT makkarrajr clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT bajwatanvir clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT kleimanneal clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT linkeaxel clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT kereiakesdeanj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT waksmanron clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT alloccodominicj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT rizikdavidg clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT reardonmichaelj clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement
AT lindmanbrianr clinicalimplicationsofphysicalfunctionandresilienceinpatientsundergoingtranscatheteraorticvalvereplacement